The use of Meta‐Analysis Risk Estimates for Candidate Genes in Combination to Predict Coronary Heart Disease Risk
Open Access
- 30 March 2007
- journal article
- research article
- Published by Wiley in Annals of Human Genetics
- Vol. 71 (5) , 611-619
Abstract
Summary: Although the risk for coronary heart disease (CHD) associated with single SNPs is modest it has been suggested that, in combination, several common risk‐associated alleles could lead to a substantially better heart disease risk prediction. We have modelled this using 10 SNPs in ten candidate genes (APOB, NOS3, APOE, ACE, SERPINE1, MTHFR, ITGA2B, PON 1, LPL, and CETP) and their predicted summary risk estimates from meta‐analysis. Based on published allele frequencies, ∼29% of the general population would be expected to carry less than three risk alleles, approximately 55% would carry 3 or 4 risk alleles, 4% would have 6 and 1% 7 or more risk alleles. Compared to the mean of those with 3 or 4 risk associated genotypes, those with 6 and 7‐or‐more alleles have a significantly higher risk odds ratio (OR) of CHD (mean OR (95% Confidence Intervals), 1.70 (1.14 to 2.55); and 4.51 (2.89 to 7.04) respectively), while compared to those in the lowest decile of risk, those in the highest decile have a CHD odds ratio in the range of 3.05 (2.24 to 4.14). Taking into account age and the risk alleles carried, the mean 10 year probability for developing CHD for a 55 year old man was calculated to be 15% (8.6% to 24.8%), with nearly 1 in 5 having more than 20% risk. Whether this particular group of 10 SNPs will improve the accuracy of CHD predictions over the combination of classical risk factors in clinical use requires further experimental evidence.Keywords
This publication has 24 references indexed in Scilit:
- Investigating the Genetic Determinants of Cardiovascular Disease Using Candidate Genes and Meta‐analysis of Association StudiesAnnals of Human Genetics, 2006
- JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practiceHeart, 2005
- The Significant Increase in Cardiovascular Disease Risk in APOEɛ4 Carriers is Evident Only in Men Who Smoke: Potential Relationship Between Reduced Antioxidant Status and ApoE4Annals of Human Genetics, 2005
- A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart StudyAtherosclerosis, 2005
- Smoking, apolipoprotein???E genotype, and early onset of coronary heart diseaseEuropean Journal of Preventive Cardiology, 2005
- Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin TreatmentCirculation, 2005
- Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart DiseaseCirculation, 2004
- Usefulness of the Initial Noninvasive Imaging Study to Predict the Adverse Outcomes in the Medical Treatment of Acute Type A Aortic Intramural HematomaCirculation, 2003
- Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε4 genotypeThe Lancet, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001